Neprilysin Inhibition and Effects on Kidney Function and Surrogates of Cardiovascular Risk in Chronic Kidney Disease

Circulation. 2018 Oct 9;138(15):1515-1518. doi: 10.1161/CIRCULATIONAHA.118.036523.
No abstract available

Keywords: Editorials; chronic kidney disease; clinical trial; sacubitril/valsartan.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Aminobutyrates
  • Biphenyl Compounds
  • Cardiovascular Diseases*
  • Drug Combinations
  • Humans
  • Irbesartan
  • Neprilysin
  • Renal Insufficiency, Chronic*
  • Risk Factors
  • Tetrazoles
  • Valsartan

Substances

  • Aminobutyrates
  • Biphenyl Compounds
  • Drug Combinations
  • Tetrazoles
  • Valsartan
  • Neprilysin
  • Irbesartan
  • sacubitril and valsartan sodium hydrate drug combination